Methyl 3-bromocyclopentanecarboxylate

Catalog No. :
ACNTOB710
CAS No. :
1311312-00-1
Molecular Formula :
C7H11BrO2
Molecular Weight :
207.07

IUPAC Name:methyl 3-bromocyclopentane-1-carboxylate

Methyl 3-bromocyclopentanecarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$677.00Login to see priceIn stockInquiry
250mg95%$1081.00Login to see priceIn stockInquiry
500mg95%$1802.00Login to see priceIn stockInquiry
1g95%$2701.00Login to see priceIn stockInquiry
5g95%$8102.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-bromocyclopentanecarboxylate
IUPAC Namemethyl 3-bromocyclopentane-1-carboxylate
MDL No.MFCD00092316
Molecular FormulaC7H11BrO2
Molecular Weight207.07
SMILESO=C(C1CC(Br)CC1)OC
InChI KeyNBNSTTSIQITBMQ-UHFFFAOYSA-N
Synonymmethyl 3-bromocyclopentanecarboxylate;methyl 3-bromocyclopentane-1-carboxylate;Cyclopentanecarboxylic acid, 3-bromo-, methyl ester
CAS No.1311312-00-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACNTOB710 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWCGO375 route compound structure diagram
    ACWCGO37532811-76-0 In Stock
  4. Then
  5. ACNTOB710 route product structure diagram
    ACNTOB7101311312-00-1 In Stock
Inquiry

2. ACNTOB710 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNTOB710 route product structure diagram
    ACNTOB7101311312-00-1 In Stock
Inquiry

Comments (0)